CLINICAL_TRIALS
trial_result
· 2017-04-10
Clinical Trial Update: A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol [Phase 4]
Summary
A Phase 4 clinical trial update evaluating whether post-reactivation propranolol can weaken traumatic memories in people with PTSD.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Posttraumatic Stress Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-04-10